Schedule 13G ownership disclosure

Oramed Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 68403P203

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
933,050
Percent of class
5.3700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000041
Form type
SC 13G/A
Filer
ORAMED PHARMACEUTICALS INC.
CIK
CIK 1176309
Filed
Jan 07, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub